A cancer cell is unique from its genetic makeup to its microenvironment. Molecular diagnostics can be leveraged to screen a tumor’s molecular profile delivering information to support the identification of the right target - for the right individual, at the right dose, and at the right time. This is based on biomarkers identified by analyzing a tumor’s genome (DNA) or transcriptome (mRNA). The integration of this information can provide a detailed molecular picture of tumors and improve the likelihood that individuals will benefit from treatment.
We offer innovative, end-to-end workflows for biomarker identification and characterization as well as applications that enable labs to translate insights into decisions rapidly and efficiently. Adaptable and scalable solutions allow labs to minimize errors, reduce hands-on time, and increase throughput and reproducibility. Flexible modules, based on your testing and throughput requirements, can be used to meet your lab’s current and future needs.
Products may not be licensed in accordance with the laws in all countries, such as the United States and Canada. Please check with your local representative for availability. Analyte Specific Reagent. Analytical and performance characteristics are not established.
For research use only. Not for use in diagnostic procedures.